Pricing Log in Create free account

Lakefront Biotherapeutics - Sponsored ADR (LKFT) vs Palvella Therapeutics, Inc. (PVLA)

Lakefront Biotherapeutics - Sponsored ADR and Palvella Therapeutics, Inc. are both Biotechnology companies. Lakefront Biotherapeutics - Sponsored ADR and Palvella Therapeutics, Inc. are of similar size ($2.3B and $2.2B). Palvella Therapeutics, Inc. grew revenue faster over the last twelve months: 146.7% against −52.2%. Palvella Therapeutics, Inc. has the higher net margin (0.00% vs −6.81%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Lakefront Biotherapeutics - Sponsored ADR leads on 10 and Palvella Therapeutics, Inc. on 6.

Valuation

Metric LKFT PVLA Biotechnology median
P/E n/m n/m 10.26
P/S 7.87 54.15 9.18
P/B 0.58 10.38 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.91 n/m 0.65
EV/Sales (1.35) 48.15 8.98
Earnings yield (0.85%) (3.08%) (34.89%)
Free cash flow yield (26.89%) (1.43%) (24.52%)

Profitability

Metric LKFT PVLA Biotechnology median
Gross margin 89.75% 100.00% 65.16%
Operating margin (90.11%) 0.00% 0.00%
Net margin (6.81%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (46.63%) (50.12%)
Return on assets 0.00% (37.70%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LKFT PVLA Biotechnology median
Revenue growth (TTM) (52.22%) 146.67% 6.26%
EPS growth (last fiscal year) 355.37% 52.62% 29.88%
Revenue growth, 5-year CAGR 15.75% 8.03% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LKFT PVLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 32.84 21.18 4.89
Net debt to EBITDA (8.53) 1.50 1.01

Dividend

Metric LKFT PVLA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LKFT PVLA Biotechnology median
Market cap 2.20b 2.26b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack